newsfilter
← Latest News
Business Wire·

Cue Health Achieves Groundbreaking Milestone with FDA: First Company to Receive De Novo Authorization for a COVID-19 Home Use Test

Cue's COVID-19 Molecular Test detects all known variants of concern and seamlessly integrates with Cue Care, the company's innovative test-to-treatment platform Cue Health (NASDAQ:HLTH), a healthcare technology